Inventor · disambiguated record
Shannon Werner
Also filed as: WERNER SHANNON
1 granted patent·5 pending applications·7 citations·filing 2012–2019
37Inventor score
Top patents by PatentIndex Score
6 records- 0182US8691231B2Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodiesBUKHALID RAGHIDA·Filed 2012·Granted Apr 8, 2014·7 cites·17 claims
- 0261US2020200752A1Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2019·Application pending·0 cites
- 0361US2014170668A1Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligandsMERRIMACK PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0459US2017356049A1Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligandsMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0555US2016083800A1Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligandsMERRIMACK PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0653US2018209982A1Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shannon Werner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →